West is First in the Region to Offer FDA-Approved PSMA PET/CT Imaging for Prostate Cancer Across All Stages

Posted by & filed under Uncategorized.

West Cancer Center & Research Institute, a pioneer in radiology technology, now has a recently FDA-approved radiopharmaceutical agent: prostate-specific membrane antigen (PSMA).  This agent will be imaged with our state-of-art PET/CT imaging for men diagnosed with prostate cancer.   According to the American Cancer Society, 1 in 8 men will be diagnosed with prostate cancer… Read more »